While previous studies have reported associations between serum CRP level and cognitive impairment under various conditions (Long et al., 2023; Wang et al., 2023), our research is the first one showing the adverse effects of serum hs-CRP level on the cognitive function of ALS patients. This evidence concerns the gene CRP and amyotrophic lateral sclerosis.